Straumann Holding AG
SIX:STMN
Straumann Holding AG
SIX:STMN
Price:
120 CHF
-0.29%
Market Closed
Updated:
May 15, 2024
P/E
Price to Earnings
Price to Earnings
77.8
Current
59.2
Median
23.9
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=77.8
Market Cap
/
19.1B
Net Income
246.1m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CH |
|
Straumann Holding AG
SIX:STMN
|
19.1B CHF | 77.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 32.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 68.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.5B USD | 36.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 26.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108B USD | 61.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 55.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 39 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.5B CNY | 31.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 36.8 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.9B USD | 78 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
38.5
2-Years Forward
P/E
31.3
3-Years Forward
P/E
26.9
You don't have any saved screeners yet
